Have you submitted your abstract for #CICON24 yet? The submission portal for abstracts will only remain open until 11:59 pm ET on Thursday, August 8, 2024. Act quickly, and submit your abstract for the Eighth International Cancer Immunotherapy Conference: Translating Science into Survival, presented by the Cancer Research Institute, and European Network for Cancer Immunotherapy, in conjunction with ENCI partner organizations, CIMT, EATI, NIBIT, and GÉTICA: https://bit.ly/43jiwso #CancerResearch #Immunotherapy #CancerResearcher
Cancer Research Institute (CRI)
Non-profit Organizations
New York, NY 93,847 followers
Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.
About us
Founded in 1953, the New York City-based Cancer Research Institute is a nonprofit organization dedicated to extending the lives of cancer patients and reducing cancer-related deaths by fueling the development of smarter, more effective treatments that mobilize our body’s natural immune defenses against all types of cancer. To accomplish this goal, the Cancer Research Institute supports the most critical research, invests in the development of promising new treatments, and unites the efforts of the field’s leaders worldwide. Through this work, Cancer Research Institute is transforming cancer therapy, enabling patients to live longer, healthier lives free from the fear of cancer. For more information visit www.cancerresearch.org.
- Website
-
http://www.cancerresearch.org
External link for Cancer Research Institute (CRI)
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Nonprofit
- Founded
- 1953
- Specialties
- cancer, immunotherapy, nonprofit, immuno-oncology, immunology, and charity
Locations
-
Primary
29 Broadway
Floor 4
New York, NY 10006-3111, US
Employees at Cancer Research Institute (CRI)
Updates
-
“I've been in remission since September 2021. I feel like I've been blessed that I was able to be on immunotherapy," shares Lenny, who was diagnosed with stage four lung cancer at age sixty two. "I think it’s a game changer.” Hear how Lenny found hope through immunotherapy, and discover more success stories on our website: https://bit.ly/4eV3xub #Immunotherapy #CancerResearch #LungCancer
-
"Adoptive cell therapies have emerged as promising approaches for the treatment of patients with cancer," Springer Nature Group's Nature Reviews Cancer describes. In a new review article, authors including CRI Scientific Advisory Council member Dr. Carl H. June of Penn Medicine, University of Pennsylvania Health System outline concepts to enhance the safety, accessibility, and efficacy of cellular immunotherapies, and discuss approaches to evade immune rejection: https://lnkd.in/e5apbEnM #CancerResearch #Immunotherapy
-
According to Weill Cornell Medicine , NewYork-Presbyterian Hospital, Icahn School of Medicine at Mount Sinai, and Columbia University Vagelos College of Physicians and Surgeons researchers, including former Wade F. B. Thompson CLIP Investigator Dr. Suzanne Lentzsch, a routine blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether patients with relapsed multiple myeloma will respond well to CAR T cell therapy. Discover: https://bit.ly/46hWfwC #MultipleMyeloma #CancerResearch #Immunotherapy
Routine Blood Test May Guide Use of Multiple Myeloma Immunotherapy | NYP
nyp.org
-
Join us at #CICON24 to be a part of the transformative dialogue shaping the future of cancer immunotherapy! Register now to attend the Eighth International Cancer Immunotherapy Conference: Translating Science into Survival, held on September 8-11, 2024, in National Harbor, MD: https://bit.ly/3wkc5sQ #CancerResearch #Immunotherapy #CancerResearcher
-
What types of cancers can immunotherapy treat, and what is the difference between chemotherapy and immunotherapy? Discover the Cancer Research Institute's answers to your most frequently asked immunotherapy questions, on our website: https://bit.ly/3ORCHYJ #CancerResearch #CancerResearcher #Immunotherapy
What Is Immunotherapy? | Cancer Research Institute
https://www.cancerresearch.org
-
Diagnosed with a rare cancer, Tina was informed that she had less than 12 months to live, and enrolled in the TOPAZ-1 trial. During her first scan, she says, “there was shrinkage! I just started crying. I was so happy because that gave me so much hope.” Discover the power of immunotherapy, and hear more of Tina's story, on our website: https://bit.ly/4biqF2G #CancerResearch #ClinicalTrial #Immunotherapy
-
In the past few years, #TeamCRI fundraiser Omar has seen family and friends affected by cancer. Aiming to make a difference by taking on a record-breaking challenge, Omar created #DriveOutCancer24 to claim the world record for most indoor golf simulator holes played in a 24-hour period. On June 28, 2024, he succeeded in achieving his goal, and set a new record by completing 702 holes in 22 hours and 19 minutes, beating the previous record of 666, and raising over $20,000 for the Cancer Research Institute! Read more: https://bit.ly/3xTAVkv #CancerResearch #CommunityFundraising #PeertoPeerFundraiser
DriveOutCancer24: Omar Ghaffar Sets Golf World Record While Raising Over $20,000 for CRI - Cancer Research Institute
https://www.cancerresearch.org
-
A second round of abstract submission is open for #CICON24! Submit an abstract before 11:59 pm ET on August 8 to be a part of the conversation shaping the future of cancer treatment. Don't miss this opportunity to showcase your research to a prestigious audience, and to collaborate with colleagues from around the world. Submit your abstract today: https://bit.ly/43jiwso #CancerResearch #Immunotherapy #CancerResearcher #AbstractSubmission
-
Did you know? UV radiation damages skin cells and can cause skin cancer. Additionally, UV rays can diminish the immune system’s natural ability to fight off chronic diseases, such as cancer. “Too much UV exposure damages the DNA,” emphasizes CRI-Irvington Postdoctoral Fellow Dr. Ayana Ruffin of Emory University. Dr. Ruffin’s research compares how genetic mutations in melanoma cases, which result from UV ray exposure, affect immune responses. “When this damage is not repaired it leads to mutations in the genes that control cell growth, leading to the development of cancers like melanoma.” While there are three main types of skin cancers, melanoma is considered the deadliest, despite accounting for less than five percent of cases. Discover factors that affect your UV exposure, explore how immunotherapy has opened new avenues of treatment for melanoma in recent years, and learn how researchers funded by the Cancer Research Institute are working on novel melanoma immunotherapy research, during UV Safety Awareness Month: https://bit.ly/3zKBVHX #CancerResearch #Immunotherapy #Melanoma #UVSafetyAwarenessMonth
UV Safety Awareness Month: Shining a Light on Melanoma Prevention - Cancer Research Institute
https://www.cancerresearch.org